233 related articles for article (PubMed ID: 6546902)
1. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
[TBL] [Abstract][Full Text] [Related]
2. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
[TBL] [Abstract][Full Text] [Related]
3. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
4. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
6. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
7. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
Schumacher WA; Lucchesi BR
J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
[TBL] [Abstract][Full Text] [Related]
8. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
[TBL] [Abstract][Full Text] [Related]
9. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
10. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
11. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
12. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
14. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
Bache RJ; Dai XZ
Cardiovasc Res; 1992 Apr; 26(4):351-6. PubMed ID: 1638566
[TBL] [Abstract][Full Text] [Related]
15. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT
Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298
[No Abstract] [Full Text] [Related]
17. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
18. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
